Spero Therapeutics SPRO
NASDAQ SPRO
$1.11 -0.02 (-1.77%)
At close: Oct 23, 2026 · 4:00 PM EDT

Spero Therapeutics (SPRO) Return on Invested Capital [ROIC] (2023 - 2024)

Updated

Spero Therapeutics (SPRO) posted Return on Invested Capital [ROIC] of 11.64% for FY2025.

Analysis

Spero Therapeutics (SPRO) Return on Invested Capital [ROIC] (2023 - 2024) Analysis & Trends

  • Business Quant data shows SPRO's Return on Invested Capital [ROIC] at 21.08% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.57%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 18.68%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 3.56%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 34.87%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 23.26%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 14.33%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -5.97%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 13.44%
10 Spero Therapeutics 64.54 Mn -131.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -131.42%
Sep 30, 2024 -0.31%
Dec 31, 2023 23.99%
API Access

Spero Therapeutics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=SPRO&period=max&api_key=YOUR_API_KEY